Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans - Biology of Blood and Marrow Transplantation
ReadiUse™ 6-Color Human TBNK Antibody Kit *Dry Reagent Format* | AAT Bioquest
Markers expressed at significantly different levels in ALL cells and in... | Download Scientific Diagram
Reference values for B-cell surface markers and co-receptors associated with primary immune deficiencies in healthy Turkish children - Elif Azarsiz, Neslihan Edeer Karaca, Guzide Aksu, Necil Kutukculer, 2017
CD19 Antibody, anti-human, REAlease® | Releasable antibodies | MACS Antibodies | Products | Miltenyi Biotec | Lëtzebuerg
Confocal microscopy. Detection of CD3 ( green fluorescence ) and CD19 (... | Download Scientific Diagram
RB780 Mouse Anti-Human CD19
R718 Mouse Anti-Human CD19
Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
BV605 Mouse Anti-Human CD19
Analyzing Single Cells with Flow Cytometry
Frontiers | Development of a Novel Anti-CD19 CAR Containing a Fully Human scFv and Three Costimulatory Domains
CD19 Monoclonal Antibody (HIB19), PerCP-Cyanine5.5 (45-0199-42)
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
Representative flow cytometric antigen expression patterns in normal... | Download Scientific Diagram
BV421 Rat Anti-Mouse CD19
CD19 - The Marker, the Antibodies | Bio-Rad
A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library
CD19 antibody (27949-1-AP) | Proteintech
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
